Stricker R B, Linker C A, Crowley T J, Embury S H
Am J Hematol. 1986 Feb;21(2):223-30. doi: 10.1002/ajh.2830210212.
Hematologic malignancy has rarely been reported in adults with sickle cell disease. We describe four sickle cell patients (two with hemoglobin SC, two with hemoglobin SS) who developed hematologic malignancy (acute myeloblastic leukemia, multiple myeloma, malignant histiocytosis, and Hodgkin's disease). Three of the cases represent the first adult association between SC or SS hemoglobinopathy and the particular malignancy involved. Sickle hemoglobin does not appear to exert a protective effect against childhood hematologic malignancies, suggesting that better survival in sickle cell disease may be accompanied by an increased incidence of hematologic neoplasms in adulthood. Karyotypic analysis revealed alterations of chromosome 5 in two sickle cell patients with leukemia, raising the possibility of a chromosomal link between the two diseases. Further epidemiologic and cytogenetic studies are needed to define the relationship between hematologic malignancy and sickle cell disease.
血液系统恶性肿瘤在成年镰状细胞病患者中鲜有报道。我们描述了4例镰状细胞病患者(2例血红蛋白为SC型,2例血红蛋白为SS型),他们均发生了血液系统恶性肿瘤(急性髓细胞白血病、多发性骨髓瘤、恶性组织细胞增多症和霍奇金病)。其中3例病例代表了SC或SS血红蛋白病与所涉及的特定恶性肿瘤之间首次在成人中的关联。镰状血红蛋白似乎对儿童血液系统恶性肿瘤没有保护作用,这表明镰状细胞病患者较好的生存率可能伴随着成年期血液系统肿瘤发病率的增加。核型分析显示,2例患白血病的镰状细胞病患者存在5号染色体改变,这增加了两种疾病之间存在染色体关联的可能性。需要进一步的流行病学和细胞遗传学研究来明确血液系统恶性肿瘤与镰状细胞病之间的关系。